[Deswell Announces Filing and Availability of Annual Report on Form 20-F Deswell Industries, Inc. (Nasdaq: DSWL) http://www.sec.gov MACAO--(BUSINESS WIRE)--July 28, 2016-- The Company will deliver a paper copy of its fiscal 2016 Annual Report on Form 20-F, including its complete audited financial statements, free of charge, to any shareholder within a reasonable time after request. To obtain a paper copy]
[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT ON ESTIMATED PROFIT DECREASE FOR THE FIRST HALF OF 2016 Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company. Company SFO Listing Rules This announcement] [Description 99.1 Announcement, dated July 29, 2016 China Life Insurance Company Limited]
[China Nepstar Chain Drugstore Ltd. Announces Shareholders Vote to Approve Merger Immediately after the completion of the merger, Parent will continue to be beneficially owned by Mr. Simin Zhang, chairman of the board of directors of the Company. Approximately 88.6% of the Company’s total outstanding ordinary shares voted in person or by proxy at the extraordinary general meeting. Of these] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan District Shenzhen, Guangdong Province 518057 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD. Zixin Shao Chief Financial Officer]
[China Nepstar Chain Drugstore Ltd. Announces Shareholders Vote to Approve Merger Immediately after the completion of the merger, Parent will continue to be beneficially owned by Mr. Simin Zhang, chairman of the board of directors of the Company. Approximately 88.6% of the Company’s total outstanding ordinary shares voted in person or by proxy at the extraordinary general meeting. Of these] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan District Shenzhen, Guangdong Province 518057 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD. Zixin Shao Chief Financial Officer]
[CONTACT: Gary S. Maier Maier & Company, Inc. (310) 471-1288 HIGHWAY HOLDINGS LIMITED DECLARES CASH DIVIDEND HONG KONG – July 18, 2016 -- (Nasdaq:HIHO) About Highway Holdings Highway Holdings produces a wide variety of high-quality products for blue chip original equipment manufacturers -- from simple parts and components to sub-assemblies and finished products. Highway Holdings’ administrative offices are located in] []
[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report. . . . . . . . . . . . . . . . . . . . For the transition period from to iKang Healthcare Group, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) B-6F, Shimao Tower 92A] [New China Life Insurance Co., Ltd. (NCI), iKang Guobin Healthcare Group Co., Ltd. (iKang), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (Top Spring Pu Chang) and New China Life Insurance Health Investment Management Co., Ltd. (the Target Company) entered into the Capital Injection Agreement (the Agreement) on December 4, 2015, as supplemented by the Supplemental Agreement to the] [iKang Healthcare Technology Group Co., Ltd. (the Borrower) and AVIC Trust Co., Ltd. (the Lender) entered into the Loan Agreement (the Agreement) on December 9, 2015. Article 1. The Loan Amount The amount of loan (Loan) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 2.2 Article 3. Term of the Loan. 3.1 3.2 1 3.3 3.4 3.5 3.6] [Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (Party A) and iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) (i) 1] [Zhongjin Zhide Equity Investment Management Co., Ltd. (Party A) and iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) 1 (i) (ii) (1) (2) (3) (4) 2 (5) Article 4. Event of Default (1) (2) (3) (4)] [Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (Party A), iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (Party C) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of] [List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong Medifast (Hong Kong) Ltd. (Causeway Bay Branch) Hong Kong Medifast (Hong Kong) Ltd. (Kowloon Branch)] [I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 2016 EX-13.1 10 a16-11673_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 201 EX-13.2 11 a16-11673_1ex13d2.htm EX-13.2] [15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 Anna.Chong@conyersdill.com Charissa.Ball@conyersdill.com The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the Company) Form 20-F Yours faithfully, EX-15.1 12 a16-11673_1ex15d1.htm EX-15.1] [July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of Item 3.D Risk Factors and Item 4.C Organizational Structure in iKang Healthcare Group, Inc.s annual report on Form 20-F for the year] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and Beijing, the Peoples Republic of China July 29, 2016 EX-15.3 14 a16-11673_1ex15d3.htm EX-15.3]
[CONTACT: Gary S. Maier Maier & Company, Inc. (310) 471-1288 HIGHWAY HOLDINGS LIMITED DECLARES CASH DIVIDEND HONG KONG – July 18, 2016 -- (Nasdaq:HIHO) About Highway Holdings Highway Holdings produces a wide variety of high-quality products for blue chip original equipment manufacturers -- from simple parts and components to sub-assemblies and finished products. Highway Holdings’ administrative offices are located in] []
[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report. . . . . . . . . . . . . . . . . . . . For the transition period from to iKang Healthcare Group, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) B-6F, Shimao Tower 92A] [New China Life Insurance Co., Ltd. (NCI), iKang Guobin Healthcare Group Co., Ltd. (iKang), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (Top Spring Pu Chang) and New China Life Insurance Health Investment Management Co., Ltd. (the Target Company) entered into the Capital Injection Agreement (the Agreement) on December 4, 2015, as supplemented by the Supplemental Agreement to the] [iKang Healthcare Technology Group Co., Ltd. (the Borrower) and AVIC Trust Co., Ltd. (the Lender) entered into the Loan Agreement (the Agreement) on December 9, 2015. Article 1. The Loan Amount The amount of loan (Loan) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 2.2 Article 3. Term of the Loan. 3.1 3.2 1 3.3 3.4 3.5 3.6] [Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (Party A) and iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) (i) 1] [Zhongjin Zhide Equity Investment Management Co., Ltd. (Party A) and iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) 1 (i) (ii) (1) (2) (3) (4) 2 (5) Article 4. Event of Default (1) (2) (3) (4)] [Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (Party A), iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (Party C) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of] [List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong Medifast (Hong Kong) Ltd. (Causeway Bay Branch) Hong Kong Medifast (Hong Kong) Ltd. (Kowloon Branch)] [I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 2016 EX-13.1 10 a16-11673_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 201 EX-13.2 11 a16-11673_1ex13d2.htm EX-13.2] [15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 Anna.Chong@conyersdill.com Charissa.Ball@conyersdill.com The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the Company) Form 20-F Yours faithfully, EX-15.1 12 a16-11673_1ex15d1.htm EX-15.1] [July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of Item 3.D Risk Factors and Item 4.C Organizational Structure in iKang Healthcare Group, Inc.s annual report on Form 20-F for the year] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and Beijing, the Peoples Republic of China July 29, 2016 EX-15.3 14 a16-11673_1ex15d3.htm EX-15.3]
